Urgent Product Defect Correction: Android FreeStyle LibreLink app on Android 13 operating system (OS) 21 February 2023 The Android 13 operating system update was recently released and made available to Android phones. Abbott Diabetes Care has recently discovered that when using smartphones with the Android 13 operating system, users may experience extended periods of signal loss in the FreeStyle LibreLink app. In these situations, users of glucose alarms may not receive low glucose and high glucose alarms. This does not impact the ability to get glucose readings by scanning the sensor. Abbott advises that if you have not installed Android 13 OS, to consider waiting until the FreeStyle LibreLink app update becomes available in the coming weeks. For more information visit: https://www.freestylelibre.com.au/app-update or call the FreeStyle Libre customer service team on 1800 801 478 between 8am and 6pm AEDT, Monday – Friday, for further support.
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
Blog 27 May 2026 How diabetes, depression, anxiety, and medicines are connected People with diabetes can be depressed or anxious more often than people without diabetes. Studies show that when you have diabetes, you are almost twice as likely to be depressed, regardless of the type of diabetes. Continue Reading
